nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.112	0.216	CbGbCtD
Oxymorphone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0852	0.164	CbGbCtD
Oxymorphone—CYP3A4—Betamethasone—psoriatic arthritis	0.0731	0.14	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—psoriatic arthritis	0.0721	0.139	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—psoriatic arthritis	0.0681	0.131	CbGbCtD
Oxymorphone—CYP2D6—Dexamethasone—psoriatic arthritis	0.0669	0.129	CbGbCtD
Oxymorphone—CYP3A4—Dexamethasone—psoriatic arthritis	0.0425	0.0817	CbGbCtD
Oxymorphone—Visual disturbance—Methotrexate—psoriatic arthritis	0.00173	0.00361	CcSEcCtD
Oxymorphone—Abdominal distension—Prednisone—psoriatic arthritis	0.00171	0.00356	CcSEcCtD
Oxymorphone—Hallucination—Methylprednisolone—psoriatic arthritis	0.00171	0.00356	CcSEcCtD
Oxymorphone—Lethargy—Methotrexate—psoriatic arthritis	0.00167	0.00349	CcSEcCtD
Oxymorphone—Sweating increased—Prednisone—psoriatic arthritis	0.00165	0.00345	CcSEcCtD
Oxymorphone—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00165	0.00345	CcSEcCtD
Oxymorphone—Eye disorder—Methylprednisolone—psoriatic arthritis	0.0016	0.00334	CcSEcCtD
Oxymorphone—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00159	0.00332	CcSEcCtD
Oxymorphone—Bradycardia—Betamethasone—psoriatic arthritis	0.00159	0.00331	CcSEcCtD
Oxymorphone—Bradycardia—Dexamethasone—psoriatic arthritis	0.00159	0.00331	CcSEcCtD
Oxymorphone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00156	0.00325	CcSEcCtD
Oxymorphone—Hallucination—Dexamethasone—psoriatic arthritis	0.00155	0.00324	CcSEcCtD
Oxymorphone—Hallucination—Betamethasone—psoriatic arthritis	0.00155	0.00324	CcSEcCtD
Oxymorphone—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00155	0.00323	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00155	0.00322	CcSEcCtD
Oxymorphone—Weight decreased—Prednisone—psoriatic arthritis	0.00154	0.0032	CcSEcCtD
Oxymorphone—Vision blurred—Prednisolone—psoriatic arthritis	0.00153	0.0032	CcSEcCtD
Oxymorphone—Visual impairment—Dexamethasone—psoriatic arthritis	0.0015	0.00313	CcSEcCtD
Oxymorphone—Visual impairment—Betamethasone—psoriatic arthritis	0.0015	0.00313	CcSEcCtD
Oxymorphone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.0015	0.00313	CcSEcCtD
Oxymorphone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00149	0.00311	CcSEcCtD
Oxymorphone—Vertigo—Prednisolone—psoriatic arthritis	0.00146	0.00305	CcSEcCtD
Oxymorphone—Syncope—Prednisolone—psoriatic arthritis	0.00146	0.00304	CcSEcCtD
Oxymorphone—Eye disorder—Betamethasone—psoriatic arthritis	0.00146	0.00304	CcSEcCtD
Oxymorphone—Eye disorder—Dexamethasone—psoriatic arthritis	0.00146	0.00304	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00143	0.00298	CcSEcCtD
Oxymorphone—Angiopathy—Dexamethasone—psoriatic arthritis	0.00142	0.00295	CcSEcCtD
Oxymorphone—Angiopathy—Betamethasone—psoriatic arthritis	0.00142	0.00295	CcSEcCtD
Oxymorphone—Convulsion—Prednisolone—psoriatic arthritis	0.00141	0.00294	CcSEcCtD
Oxymorphone—Hypertension—Prednisolone—psoriatic arthritis	0.00141	0.00293	CcSEcCtD
Oxymorphone—Bradycardia—Prednisone—psoriatic arthritis	0.00138	0.00288	CcSEcCtD
Oxymorphone—Hallucination—Prednisone—psoriatic arthritis	0.00135	0.00282	CcSEcCtD
Oxymorphone—Vertigo—Triamcinolone—psoriatic arthritis	0.00134	0.0028	CcSEcCtD
Oxymorphone—Syncope—Triamcinolone—psoriatic arthritis	0.00134	0.0028	CcSEcCtD
Oxymorphone—Vertigo—Methylprednisolone—psoriatic arthritis	0.00134	0.0028	CcSEcCtD
Oxymorphone—Syncope—Methylprednisolone—psoriatic arthritis	0.00134	0.00279	CcSEcCtD
Oxymorphone—Oedema—Prednisolone—psoriatic arthritis	0.00133	0.00277	CcSEcCtD
Oxymorphone—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00132	0.00274	CcSEcCtD
Oxymorphone—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00131	0.00274	CcSEcCtD
Oxymorphone—Shock—Prednisolone—psoriatic arthritis	0.00131	0.00272	CcSEcCtD
Oxymorphone—Convulsion—Triamcinolone—psoriatic arthritis	0.0013	0.0027	CcSEcCtD
Oxymorphone—Tachycardia—Prednisolone—psoriatic arthritis	0.0013	0.0027	CcSEcCtD
Oxymorphone—Convulsion—Methylprednisolone—psoriatic arthritis	0.00129	0.0027	CcSEcCtD
Oxymorphone—Hypertension—Triamcinolone—psoriatic arthritis	0.00129	0.00269	CcSEcCtD
Oxymorphone—Hypertension—Methylprednisolone—psoriatic arthritis	0.00129	0.00269	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00128	0.00268	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—psoriatic arthritis	0.00127	0.00265	CcSEcCtD
Oxymorphone—Eye disorder—Prednisone—psoriatic arthritis	0.00127	0.00265	CcSEcCtD
Oxymorphone—Anxiety—Methylprednisolone—psoriatic arthritis	0.00127	0.00264	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00126	0.00263	CcSEcCtD
Oxymorphone—Flushing—Prednisone—psoriatic arthritis	0.00126	0.00263	CcSEcCtD
Oxymorphone—Dry mouth—Triamcinolone—psoriatic arthritis	0.00125	0.0026	CcSEcCtD
Oxymorphone—Angiopathy—Prednisone—psoriatic arthritis	0.00123	0.00257	CcSEcCtD
Oxymorphone—Confusional state—Methylprednisolone—psoriatic arthritis	0.00123	0.00256	CcSEcCtD
Oxymorphone—Immune system disorder—Prednisone—psoriatic arthritis	0.00123	0.00256	CcSEcCtD
Oxymorphone—Oedema—Triamcinolone—psoriatic arthritis	0.00122	0.00255	CcSEcCtD
Oxymorphone—Vertigo—Betamethasone—psoriatic arthritis	0.00122	0.00254	CcSEcCtD
Oxymorphone—Vertigo—Dexamethasone—psoriatic arthritis	0.00122	0.00254	CcSEcCtD
Oxymorphone—Syncope—Dexamethasone—psoriatic arthritis	0.00122	0.00254	CcSEcCtD
Oxymorphone—Syncope—Betamethasone—psoriatic arthritis	0.00122	0.00254	CcSEcCtD
Oxymorphone—Shock—Triamcinolone—psoriatic arthritis	0.0012	0.00251	CcSEcCtD
Oxymorphone—Insomnia—Prednisolone—psoriatic arthritis	0.0012	0.0025	CcSEcCtD
Oxymorphone—Shock—Methylprednisolone—psoriatic arthritis	0.0012	0.0025	CcSEcCtD
Oxymorphone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0012	0.00249	CcSEcCtD
Oxymorphone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00119	0.00249	CcSEcCtD
Oxymorphone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00119	0.00249	CcSEcCtD
Oxymorphone—Tachycardia—Triamcinolone—psoriatic arthritis	0.00119	0.00249	CcSEcCtD
Oxymorphone—Mental disorder—Prednisone—psoriatic arthritis	0.00119	0.00248	CcSEcCtD
Oxymorphone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00119	0.00248	CcSEcCtD
Oxymorphone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00118	0.00247	CcSEcCtD
Oxymorphone—Malnutrition—Prednisone—psoriatic arthritis	0.00118	0.00247	CcSEcCtD
Oxymorphone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00118	0.00246	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00118	0.00246	CcSEcCtD
Oxymorphone—Convulsion—Dexamethasone—psoriatic arthritis	0.00118	0.00245	CcSEcCtD
Oxymorphone—Convulsion—Betamethasone—psoriatic arthritis	0.00118	0.00245	CcSEcCtD
Oxymorphone—Hypertension—Betamethasone—psoriatic arthritis	0.00117	0.00244	CcSEcCtD
Oxymorphone—Hypertension—Dexamethasone—psoriatic arthritis	0.00117	0.00244	CcSEcCtD
Oxymorphone—Anxiety—Dexamethasone—psoriatic arthritis	0.00115	0.0024	CcSEcCtD
Oxymorphone—Anxiety—Betamethasone—psoriatic arthritis	0.00115	0.0024	CcSEcCtD
Oxymorphone—Hypotension—Methylprednisolone—psoriatic arthritis	0.00114	0.00237	CcSEcCtD
Oxymorphone—Pain—Prednisolone—psoriatic arthritis	0.00114	0.00237	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00112	0.00234	CcSEcCtD
Oxymorphone—Vision blurred—Prednisone—psoriatic arthritis	0.00111	0.00232	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—psoriatic arthritis	0.00111	0.00232	CcSEcCtD
Oxymorphone—Oedema—Betamethasone—psoriatic arthritis	0.00111	0.00231	CcSEcCtD
Oxymorphone—Oedema—Dexamethasone—psoriatic arthritis	0.00111	0.00231	CcSEcCtD
Oxymorphone—Insomnia—Triamcinolone—psoriatic arthritis	0.0011	0.0023	CcSEcCtD
Oxymorphone—Insomnia—Methylprednisolone—psoriatic arthritis	0.0011	0.0023	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00109	0.00228	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—psoriatic arthritis	0.00109	0.00228	CcSEcCtD
Oxymorphone—Shock—Dexamethasone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Shock—Betamethasone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Agitation—Prednisone—psoriatic arthritis	0.00109	0.00227	CcSEcCtD
Oxymorphone—Tachycardia—Betamethasone—psoriatic arthritis	0.00108	0.00226	CcSEcCtD
Oxymorphone—Tachycardia—Dexamethasone—psoriatic arthritis	0.00108	0.00226	CcSEcCtD
Oxymorphone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00108	0.00224	CcSEcCtD
Oxymorphone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00107	0.00224	CcSEcCtD
Oxymorphone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00107	0.00223	CcSEcCtD
Oxymorphone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00107	0.00223	CcSEcCtD
Oxymorphone—Vertigo—Prednisone—psoriatic arthritis	0.00106	0.00222	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—psoriatic arthritis	0.00106	0.00221	CcSEcCtD
Oxymorphone—Syncope—Prednisone—psoriatic arthritis	0.00106	0.00221	CcSEcCtD
Oxymorphone—Anorexia—Betamethasone—psoriatic arthritis	0.00106	0.0022	CcSEcCtD
Oxymorphone—Anorexia—Dexamethasone—psoriatic arthritis	0.00106	0.0022	CcSEcCtD
Oxymorphone—Urticaria—Prednisolone—psoriatic arthritis	0.00106	0.0022	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00105	0.0022	CcSEcCtD
Oxymorphone—Fatigue—Triamcinolone—psoriatic arthritis	0.00105	0.0022	CcSEcCtD
Oxymorphone—Fatigue—Methylprednisolone—psoriatic arthritis	0.00105	0.00219	CcSEcCtD
Oxymorphone—Pain—Triamcinolone—psoriatic arthritis	0.00104	0.00218	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisone—psoriatic arthritis	0.00104	0.00217	CcSEcCtD
Oxymorphone—Hypotension—Dexamethasone—psoriatic arthritis	0.00104	0.00216	CcSEcCtD
Oxymorphone—Hypotension—Betamethasone—psoriatic arthritis	0.00104	0.00216	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—psoriatic arthritis	0.00103	0.00215	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—psoriatic arthritis	0.00103	0.00214	CcSEcCtD
Oxymorphone—Convulsion—Prednisone—psoriatic arthritis	0.00102	0.00214	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00102	0.00213	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—psoriatic arthritis	0.00102	0.00213	CcSEcCtD
Oxymorphone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00101	0.0021	CcSEcCtD
Oxymorphone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.001	0.00209	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—psoriatic arthritis	0.001	0.00209	CcSEcCtD
Oxymorphone—Insomnia—Betamethasone—psoriatic arthritis	0.001	0.00209	CcSEcCtD
Oxymorphone—Insomnia—Dexamethasone—psoriatic arthritis	0.001	0.00209	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.001	0.00208	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000997	0.00208	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—psoriatic arthritis	0.000995	0.00207	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—psoriatic arthritis	0.000988	0.00206	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000979	0.00204	CcSEcCtD
Oxymorphone—Dyspepsia—Betamethasone—psoriatic arthritis	0.000976	0.00203	CcSEcCtD
Oxymorphone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000976	0.00203	CcSEcCtD
Oxymorphone—Urticaria—Triamcinolone—psoriatic arthritis	0.00097	0.00202	CcSEcCtD
Oxymorphone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000968	0.00202	CcSEcCtD
Oxymorphone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000966	0.00201	CcSEcCtD
Oxymorphone—Oedema—Prednisone—psoriatic arthritis	0.000965	0.00201	CcSEcCtD
Oxymorphone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000963	0.00201	CcSEcCtD
Oxymorphone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000963	0.00201	CcSEcCtD
Oxymorphone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000963	0.00201	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000957	0.002	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000957	0.002	CcSEcCtD
Oxymorphone—Fatigue—Betamethasone—psoriatic arthritis	0.000956	0.00199	CcSEcCtD
Oxymorphone—Fatigue—Dexamethasone—psoriatic arthritis	0.000956	0.00199	CcSEcCtD
Oxymorphone—Shock—Prednisone—psoriatic arthritis	0.00095	0.00198	CcSEcCtD
Oxymorphone—Pain—Betamethasone—psoriatic arthritis	0.000948	0.00198	CcSEcCtD
Oxymorphone—Pain—Dexamethasone—psoriatic arthritis	0.000948	0.00198	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000947	0.00197	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—psoriatic arthritis	0.000942	0.00196	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—psoriatic arthritis	0.000937	0.00195	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000933	0.00195	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—psoriatic arthritis	0.000931	0.00194	CcSEcCtD
Oxymorphone—Anorexia—Prednisone—psoriatic arthritis	0.00092	0.00192	CcSEcCtD
Oxymorphone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000913	0.0019	CcSEcCtD
Oxymorphone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000913	0.0019	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000906	0.00189	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000906	0.00189	CcSEcCtD
Oxymorphone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0009	0.00188	CcSEcCtD
Oxymorphone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000898	0.00187	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—psoriatic arthritis	0.000888	0.00185	CcSEcCtD
Oxymorphone—Urticaria—Betamethasone—psoriatic arthritis	0.00088	0.00184	CcSEcCtD
Oxymorphone—Urticaria—Dexamethasone—psoriatic arthritis	0.00088	0.00184	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—psoriatic arthritis	0.000878	0.00183	CcSEcCtD
Oxymorphone—Asthenia—Triamcinolone—psoriatic arthritis	0.000876	0.00183	CcSEcCtD
Oxymorphone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000876	0.00183	CcSEcCtD
Oxymorphone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000876	0.00183	CcSEcCtD
Oxymorphone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000876	0.00183	CcSEcCtD
Oxymorphone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000876	0.00183	CcSEcCtD
Oxymorphone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000874	0.00182	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—psoriatic arthritis	0.000873	0.00182	CcSEcCtD
Oxymorphone—Pruritus—Triamcinolone—psoriatic arthritis	0.000864	0.0018	CcSEcCtD
Oxymorphone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000862	0.0018	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—psoriatic arthritis	0.000856	0.00179	CcSEcCtD
Oxymorphone—Dyspepsia—Prednisone—psoriatic arthritis	0.00085	0.00177	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—psoriatic arthritis	0.000841	0.00175	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—psoriatic arthritis	0.000839	0.00175	CcSEcCtD
Oxymorphone—Dermatitis—Prednisolone—psoriatic arthritis	0.000837	0.00174	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000836	0.00174	CcSEcCtD
Oxymorphone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000834	0.00174	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—psoriatic arthritis	0.000832	0.00174	CcSEcCtD
Oxymorphone—Headache—Prednisolone—psoriatic arthritis	0.000832	0.00174	CcSEcCtD
Oxymorphone—Constipation—Prednisone—psoriatic arthritis	0.000825	0.00172	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—psoriatic arthritis	0.000813	0.0017	CcSEcCtD
Oxymorphone—Dizziness—Triamcinolone—psoriatic arthritis	0.000808	0.00168	CcSEcCtD
Oxymorphone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000806	0.00168	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000795	0.00166	CcSEcCtD
Oxymorphone—Asthenia—Betamethasone—psoriatic arthritis	0.000795	0.00166	CcSEcCtD
Oxymorphone—Asthenia—Dexamethasone—psoriatic arthritis	0.000795	0.00166	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000791	0.00165	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000789	0.00165	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—psoriatic arthritis	0.000789	0.00165	CcSEcCtD
Oxymorphone—Pruritus—Dexamethasone—psoriatic arthritis	0.000784	0.00164	CcSEcCtD
Oxymorphone—Pruritus—Betamethasone—psoriatic arthritis	0.000784	0.00164	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—psoriatic arthritis	0.000783	0.00163	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00078	0.00163	CcSEcCtD
Oxymorphone—Vomiting—Triamcinolone—psoriatic arthritis	0.000777	0.00162	CcSEcCtD
Oxymorphone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000775	0.00162	CcSEcCtD
Oxymorphone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000769	0.0016	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—psoriatic arthritis	0.000769	0.0016	CcSEcCtD
Oxymorphone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000768	0.0016	CcSEcCtD
Oxymorphone—Urticaria—Prednisone—psoriatic arthritis	0.000767	0.0016	CcSEcCtD
Oxymorphone—Headache—Triamcinolone—psoriatic arthritis	0.000765	0.0016	CcSEcCtD
Oxymorphone—Headache—Methylprednisolone—psoriatic arthritis	0.000763	0.00159	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—psoriatic arthritis	0.000763	0.00159	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—psoriatic arthritis	0.000763	0.00159	CcSEcCtD
Oxymorphone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000758	0.00158	CcSEcCtD
Oxymorphone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000758	0.00158	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—psoriatic arthritis	0.000754	0.00157	CcSEcCtD
Oxymorphone—Dizziness—Betamethasone—psoriatic arthritis	0.000733	0.00153	CcSEcCtD
Oxymorphone—Dizziness—Dexamethasone—psoriatic arthritis	0.000733	0.00153	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—psoriatic arthritis	0.00073	0.00152	CcSEcCtD
Oxymorphone—Nausea—Triamcinolone—psoriatic arthritis	0.000726	0.00151	CcSEcCtD
Oxymorphone—Nausea—Methylprednisolone—psoriatic arthritis	0.000724	0.00151	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000719	0.0015	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—psoriatic arthritis	0.000717	0.0015	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisone—psoriatic arthritis	0.000711	0.00148	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—psoriatic arthritis	0.00071	0.00148	CcSEcCtD
Oxymorphone—Vomiting—Betamethasone—psoriatic arthritis	0.000705	0.00147	CcSEcCtD
Oxymorphone—Vomiting—Dexamethasone—psoriatic arthritis	0.000705	0.00147	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000701	0.00146	CcSEcCtD
Oxymorphone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000698	0.00146	CcSEcCtD
Oxymorphone—Dermatitis—Betamethasone—psoriatic arthritis	0.000698	0.00146	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000696	0.00145	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—psoriatic arthritis	0.000695	0.00145	CcSEcCtD
Oxymorphone—Headache—Dexamethasone—psoriatic arthritis	0.000694	0.00145	CcSEcCtD
Oxymorphone—Headache—Betamethasone—psoriatic arthritis	0.000694	0.00145	CcSEcCtD
Oxymorphone—Asthenia—Prednisone—psoriatic arthritis	0.000692	0.00144	CcSEcCtD
Oxymorphone—Pain—Methotrexate—psoriatic arthritis	0.00069	0.00144	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—psoriatic arthritis	0.000683	0.00142	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000665	0.00139	CcSEcCtD
Oxymorphone—Diarrhoea—Prednisone—psoriatic arthritis	0.00066	0.00138	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00066	0.00138	CcSEcCtD
Oxymorphone—Nausea—Betamethasone—psoriatic arthritis	0.000658	0.00137	CcSEcCtD
Oxymorphone—Nausea—Dexamethasone—psoriatic arthritis	0.000658	0.00137	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—psoriatic arthritis	0.000641	0.00134	CcSEcCtD
Oxymorphone—Dizziness—Prednisone—psoriatic arthritis	0.000638	0.00133	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000638	0.00133	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000638	0.00133	CcSEcCtD
Oxymorphone—Vomiting—Prednisone—psoriatic arthritis	0.000614	0.00128	CcSEcCtD
Oxymorphone—Dermatitis—Prednisone—psoriatic arthritis	0.000608	0.00127	CcSEcCtD
Oxymorphone—Headache—Prednisone—psoriatic arthritis	0.000605	0.00126	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000594	0.00124	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—psoriatic arthritis	0.000579	0.00121	CcSEcCtD
Oxymorphone—Nausea—Prednisone—psoriatic arthritis	0.000573	0.0012	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—psoriatic arthritis	0.000571	0.00119	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000552	0.00115	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—psoriatic arthritis	0.000533	0.00111	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—psoriatic arthritis	0.000513	0.00107	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—psoriatic arthritis	0.000508	0.00106	CcSEcCtD
Oxymorphone—Headache—Methotrexate—psoriatic arthritis	0.000505	0.00105	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—psoriatic arthritis	0.000479	0.000999	CcSEcCtD
